Rebalix
Logo AmundiAmundi · sheet of 10 September 2026
ETF sheet · official issuer and register data

Amundi Core Nasdaq-100 UCITS ETF Acc

ANSD · IE000A2YGZU5 · class UCITS ETF Acc · USD · domicile Ireland
Equity · United States · Large capSFDR art. 6
Index tracked: NASDAQ-100 Notional Net Total Return Index
TER
0.13%+ trans. 0.01%
Fund size
4 m EUR
Tracking difference
not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Accumulating
Launch 3 Mar 2026 · costs from the KID as of 2 Sept 2026 · 103 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 21 Aug 2026
The Fund is an index-tracking UCITS passively managed. The investment objective of the Fund is to track both the upward and the downward evolution of the NASDAQ-100 Notional Net Total Return index (the Benchmark Index") denominated in US Dollars and representative of 100 of the largest US and international non-financial companies, while minimizing the volatility of the difference between the return of the Fund and the return of the Benchmark Index (the "Tracking Error"). The anticipated level of Tracking Error in normal market conditions is indicated in…

Performance since series start (in euro) — base 100

16 Mar 20268 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
12493118
High 124 (30 Jun 2026) · low 93 (30 Mar 2026) · last 118. Past performance is not indicative of future results.

Returns in euro

1 yearseries too young
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start+18.5%

Risk · 1 / 3 / 5 years

Volatility (ann.)
Max drawdown
Sharpe
Sortino
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · ANSD · IE000A2YGZU51
RebalixANSD · IE000A2YGZU5 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years
Not honestly computable: index series not published by the issuer

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 103 securities · top-10 weight = 45.9%
Top holdingsWeight
NVIDIA CORP8.4%
APPLE INC7.6%
MICROSOFT CORP5.9%
MICRON TECHNOLOGY INC4.6%
AMAZON.COM INC4.4%
ADVANCED MICRO DEVICES3.3%
ALPHABET INC CL A3.1%
ALPHABET INC CL C2.9%
TESLA INC2.8%
BROADCOM INC2.8%
Countries (% of fund)
United States94.8%Ireland1.8%Netherlands1.3%Canada0.9%United Kingdom0.7%
Sectors (% of fund)
Information Technology58.3%Communication Services13.8%Consumer Discretionary11.0%Consumer Staples6.3%Health Care4.1%

Listing venues

ESMA register (FIRDS) and official exchange lists
ANSD · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 4 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.it/pdfDocuments/kid-priips/IE000A2YGZU5/ENG/NLD
Prospectus · www.amundietf.it/pdfDocuments/prospectus/IE000A2YGZU5/ENG/GBR
The live sheet, always up to date
rebalix.com/en/etf/IE000A2YGZU5
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · ANSD · IE000A2YGZU52